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Abstract
The folding and targeting of hydrophobic transmembrane domains poses a major challenge to the cell. Several membrane
proteins have been shown to gain some degree of secondary structure within the ribosome tunnel and to retain this conformation
throughout maturation. However, there is little information on one of the largest classes of eukaryotic membrane proteins; the G
protein-coupled receptors (GPCRs). In this study we show that the signal anchor domain of GPR35 remains in an extended
conformation whilst exiting the ribosome tunnel, the polypeptide chain then forms interactions with components of the SRP
targeting pathway, and the Sec61 translocon, resulting in a compacted conformation prior to integration into the ER membrane.
We conclude that transmembrane structure is most likely adopted after the domain leaves the ribosome tunnel and that the
interaction of the signal anchor with SRP is dependent on the native levels of hydrophobicity within the first transmembrane
domain. Therefore, we propose a mechanism by which the first transmembrane domains of multi-spanning membrane proteins
adopt compacted structures following SRP targeting but before insertion into the ER membrane.
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Introduction
The co-translational targeting of integral membrane proteins
(IMPs) poses a major challenge to the cell, as they must re-
main insertion competent while their highly hydrophobic
transmembrane domains are transferred from the ribosome,
through the aqueous cytosol and into the lipid bilayer, via
the Se61 machinery (SecYEG in bacteria). In the last decade,
increasing amounts of research has suggested that the
biogenesis of integral TM domains may begin far in advance
of reaching the translocon.
The ribosome tunnel itself has been highlighted as one of
the major sites for the generation of both secondary structure,
in the form of α-helical domains, and tertiary structure, such
as small hairpin–like domains, in membrane proteins
(Holtkamp et al. 2015). The size of the tunnel from the
peptidyl transferase centre (PTC) to the point of exit is
~100 Å in length, and its diameter ranges from 10 Å at its
narrowest point to 20 Å at the vestibule (Ban et al. 2000;
Bhushan et al. 2010; Voss et al. 2006). It has been shown to
be both structurally and biochemically diverse, housing
around 30 amino acids in an extended conformation or up to
65 amino acids in a compacted helical conformation (Lu and
Deutsch 2005a; Ziv et al. 2005). The wall of the tunnel is lined
with ribosomal RNA and ribosomal proteins (uL4, uL22 and
uL23), which have been identified to interact with the nascent
chain in a sensory and regulatory manner, often influenc-
ing processes such as biogenesis, targeting and membrane
insertion. Several studies in the last decade have provided
evidence of ribosomal proteins not only line, but protrude
into the tunnel, generating distinct zones of helix stabili-
zation that could play a key role in promoting peptide
folding (Bhushan et al. 2010; Lu and Deutsch 2005b, 2008;
Woolhead et al. 2004).
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As folded domains of TM proteins make their way to the
exit site of the tunnel, the external surface of the ribosome
becomes primed for an interaction with the signal recognition
particle (SRP). During the initial stages of SRP mediated
targeting, the ribosomal protein L17 in eukaryotes and the
tunnel loop domain of L23 in the prokaryotic ribosome were
proven to interact specifically with hydrophobic membrane
segments. Biochemical and biophysical assays have identified
that these proteins play a key role in sensing the nascent chain,
and subsequently initiate downstream events that stabilise
structure that may already be present in the nascent polypep-
tide chain (Robinson et al. 2012; Woolhead et al. 2004).
The interactions within the tunnel of the ribosome are be-
lieved to initiate SRP recruitment to the external surface, en-
abling docking on the globular domain of uL23. In eukary-
otes, SRP is made up of a large 7S RNA and 6 proteins in-
cluding SRP54 that are essential for the capture and protection
of the emerging TM domain. Upon exiting the ribosome, the
targeting component of the nascent chain is subsequently
housed in the M domain of SRP. Structural analysis of the
M domain has found that it is made up of four helices ordered
around a central hydrophobic core, which is believed to ac-
commodate ~10 residues of mainlyα-helical structure (Hainzl
et al. 2011; Janda et al. 2010; Keenan et al. 1998). This would
suggest that nascent chains choosing to interact with SRP
might be required to take up an α-helical conformation either
before or upon binding the hydrophobic groove, in line with
previous reports of signal peptides and anchors forming struc-
ture before release from the ribosome.
Further structural studies have provided us with insights
into how SRP, after binding the nascent peptide, targets to
the ribosome-nascent chain complex to the Sec61 translocon
(Kobayashi et al. 2018; Lee et al. 2018; Gao et al. 2017). The
Sec translocon, which resides in the lipid membrane as a
heterotrimeic complex, is made up of α, β and γ-subunits.
High resolution structures of the both prokaryotic and eukary-
otic Sec translocon have enabled us to deduce that the trans-
location of proteins across the membrane occurs through a
narrow pore within the complex (Voorhees et al. 2014). As
the ribosome engages the Sec translocon, a structural change
occurs, allowing the open translocon to laterally move the
nascent chain into the lipid bilayer of the ER (Plath et al.
1998; Sadlish et al. 2005; Van Den Berg et al. 2004;
Voorhees and Hegde 2016). The lateral movement of mem-
brane proteins has been well studied using both single span-
ning and polytopic membrane proteins, in which obtaining the
correct orientation and secondary structure before integration
is essential, in addition to SRP targeting the translocon pore
may aid this process (Hessa et al. 2005). Secondary structure
formation within the Sec translocon is poorly under-
stood, but there is evidence that the environment provided
by the pore could enable TM domains to sample multiple
conformations (Goder and Spiess 2003). Interactions between
the translocating nascent chain and theα-subunits of the chan-
nel, as well as accessory factors such as TRAMmay impact on
the ability of the peptide chain to fold in this environment
(Heinrich et al. 2000; McCormick et al. 2003; Sadlish et al.
2005). As secondary structure formation is deemed necessary
prior to integration, it is a realistic prospect that folding in
some domains may occur during translocation by the Sec
machinery.
In this study, we investigate the biogenesis of the signal
anchor domain of the GPCR; GPR35. A class A GPCR, this
orphan receptor will be used to report where the signal anchor
begins to form secondary structure. Using biochemical tech-
niques in both prokaryotic and eukaryotic translation systems,
we analyse secondary structure in the first TM domain as it
makes its way through the ribosome tunnel and investigate
any evolutionary differences that may exist between different
ribosome species. We show that the signal anchor domain of
GPR35 is unfolded in the upper and mid regions of the tunnel,
as well as in the lower regions where it first encounters SRP.
We show that the signal anchor of GPR35 is capable of bind-
ing SRP, an interaction driven by hydrophobicity within the
domain. Altering the hydrophobicity within the first TM seg-
ment destabilizes the interaction with SRP and subsequently
reduces insertion of GPR35 into the ER membrane. Finally,
secondary structure is measured during the insertion of the
first TM domain into the Sec61 translocon. This provides us
with evidence that the signal anchor is in an α-helical confor-
mation and the second TM domain, which resides in the
ribosome tunnel, remains extended.
Results
GPR35 signal anchor domain is extended
in the ribosome tunnel
Previous studies analysing the formation of secondary struc-
ture in both signal peptides and integral membrane domains,
have identified zones within the ribosome tunnel where con-
formational changes in the nascent peptide are likely to occur.
Conditions within both the prokaryotic and eukaryotic tunnel
have proven themselves favourable for generation of struc-
tured nascent peptides such as α-helices and tertiary hairpins
(Thommen et al. 2017). To determine whether such structural
formation is likely to occur in the signal anchor domain of a
model GPCR; GPR35, a study was set up to investigate
where, if at all, the first TM domain is likely to form a struc-
tured polypeptide. To measure compaction within a ribosome-
bound peptide, a well-practiced pegylation assay was carried
out. The success of this assay relies on the accessibility of a
molecule of PEG-MAL, to a specifically placed cysteine res-
idue (the marker cysteine (MC)) within the nascent polypep-
tide and the known dimensions of the ribosome tunnel. The
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bulky polyethelene glycol tails of PEG-MAL prevent the mol-
ecule entering far into the ribosome tunnel. Therefore,
pegylation of the MC only occurs out with the tunnel, hence
providing us with an indication of peptide compaction. To
explore the formation of secondary structure within the signal
anchor domain of GPR35, ribosome nascent chain complexes
(RNCs) were synthesized in vitro, with individual intermedi-
ates generated from linear DNA lacking a stop codon.
Intermediates of various lengths, ranging from 25-50aa from
the peptidyl transferase centre (PTC) to the MC were gener-
ated, increasing at intervals of 5aa within the range (Fig. 1a).
This set of experiments were carried out in the in vitro S-30
prokaryotic transcription/translation system (Fig. 1b). At an
intermediate length of 25aa, no pegylation took place. At this
point in the translation process, an intermediate of this length
would be expected to be buried within the ribosome tunnel,
and hence should be inaccessible to the PEG-MAL molecule
regardless of the conformation within the first TM domain. As
the nascent chain increased in length to 30aa, the MC ad-
vanced 5aa closer to the exit site. In doing so, a small fraction
of the translation product becomes pegylated resulting in a
shift in size of the translation product (Fig. 1b). As the distance
between the PTC andMC increased further, between 35-40aa,
we see greater levels of pegylation within the translation prod-
uct. Further lengths of 45aa and 50aa shows maximal levels of
pegylation (approximately 80%), suggesting the marker cys-
teine had fully exited the ribosome tunnel at that point and
becomes fully exposed. Collectively, these results indicate that
that an unstructured nascent is present in the ribosome tunnel.
To see if the lack of secondary structure within the GPR35
signal anchor was not an artefact of the prokaryotic ribosome,
a similar set of experiments were carried out in the eukaryotic
wheat germ (WG) translation system. As expected, the results
remained consistent in the eukaryotic system (Fig. 1c, d).
Pegylation of intermediates at 30aa from the PTC indicated
that the TM domain of GPR35 was unstructured in the upper
and middle regions of the ribosome tunnel. Near identical
levels of pegylation, also indicates little variation in the role
played by the respective ribosome tunnels in contributing to
secondary structure within the nascent chain (Fig. 1d).
To validate the pegylation data gathered on GPR35, two
subsequent membrane proteins were tested as controls;
Bacterioopsin (Bop) (Ortenberg and Mevarech 2000) and
subunit c of the F0 component of the ATP synthase (F0c)
(Van Der Laan et al. 2004) (Fig. S1A and S2A). Bop was used
due to its structural resemblance to a GPCR. It provided us
with a seven TM protein that was expressed natively in a
prokaryotic system, yet could be compared structurally to
the eukaryotic, GPR35. The first TM domain of Bop was
discovered to have a folding profile, which was remarkably
similar to that of GPR35 (Fig. S1B, C, D). Although, neither
the 25aa nor the 30aa intermediate could be expressed in the
S-30 system, the levels of pegylation in the 35-50aa peptides
Fig. 1 TM1 of GPR35 exists in an extended conformation in the
ribosome tunnel. (a) The first 65 residues of human GPR35 are
shown, with the position of the single cysteine (C15) residue, required
for pegylation, labelled as amino acid 1. TM domains 1 and 2 are
highlighted using boldface. Intermediate lengths of GPR35, used for
in vitro pegylation experiments, are underlined and the length is
denoted below in amino acids (aa). Autoradiographs of radiolabelled
translation products generated from stalled intermediates of between 25
and 50 amino acids in length were expressed in the (b) prokaryotic S-30
coupled transcription/translation system and the (c) eukaryotic Wheat
Germ (WG) translation system. Intermediate length was measured from
the peptidyl-transferase centre (PTC) to the marker cysteine (C15).
Translation reactions were split into two, with one half being incubated
with 1 mM PEG-MAL (+PEG-MAL) and the other half incubated in
buffer as a control (-PEG-MAL). A representative gel displays how the
non-pegylated (0) and pegylated (1) samples were resolved by SDS-
PAGE (15% Tricine). A gel-shift of ~ 5 kDa occurs if the translation
product was successfully pegylated. (d) Quantification of the total
pegylation of individual intermediates was carried out for both the S-30
transcription/translation system (●) and the WG translation system (▼).
The y-axis shows percentage of intermediates successfully pegylated and
was obtained by pixel densitometry (Image-J) and calculated using
[pegylated band/ (unpegylated band + pegylated band)]. The average
percentage pegylation is calculated from an n = 3 replicates, error bars
are + SD
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followed an identical pattern to that data gathered with
GPR35. A full range of intermediates could be expressed in
the WG expression system and they showed consistent levels
of pegylation to GPR35. This suggested that the first TM
domain of Bop traversed the ribosome in an unstructured
state, eluding to a possible trend in seven TM domain
proteins. The F0c protein, previously shown by Robinson
et al. (2012) to compact in the ribosome tunnel, showed a very
different pegylation profile. Ribosome nascent chain com-
plexes (RNCs) were synthesized in the S-30 expression sys-
tem only, with intermediates ranging in size from 35-70aa,
taking into account the likelihood that compaction would oc-
cur. At 35aa from the PTC, the MC remained unpegylated
unlike the same sized intermediates in GPR35 and Bop. The
first indication of pegylation of F0c was when the MC was
approximately 45aa from the PTC suggesting compaction of
the nascent chain was occurring. Following this, further inter-
mediates became maximally pegylated (approximately 80%)
maintaining a similar trend to the previous assays.
The pegylation assays led to the conclusion that GPR35
exists in an extended conformation and shows no sign of
forming secondary structure, in the ribosome tunnel. This re-
sult compares well with previous studies that found extended
peptides (3.4 Å per aa) would require approximately 30aa to
traverse the ribosome tunnel, where as a fully compacted pep-
tide would require approximately 65aa (1.5 Å/aa) to span the
same distance (Lu and Deutsch 2005a). If compaction of the
signal anchor did occur the MC would be labelled approxi-
mately 45aa from the PTC and not before, with this data
therefore ruling out the existence of significant secondary
structure within the exit tunnel.
GPR35 signal anchor reaches SRP as an extended
nascent chain
To explore further the conformational changes occurring in the
nascent chain of GPR35 as it becomes exposed at the exit site of
the ribosome, and subsequently undergoes the process of mem-
brane targeting, an assay was set up to utilize the prospective in-
teraction with SRP. Using the chemical cross-linker
bis(sulfosuccinimidyl)suberate (BS3), we attempted to monitor in-
teractions between the nascent chain and components of the SRP
targeting pathway, and imply from these the conformational chang-
es occurring in the signal anchor domain as it encounters SRP.
A single lysine residue (K20), found 5aa upstream of the
signal anchor, makes the GPR35WTconstruct suitable for this
cross-linking assay as it has a native marker lysine (MK) for
interacting with BS3. Initial experiments were performed in
the prokaryotic S-30 in vitro transcription/translation expres-
sion system, as antibodies for the detection of SRP targeting
components uL23 and Ffh (bacterial SRP54) were available.
As the bacterial and eukaryotic SRP pathways share common
ancestry, we were confident that interactions between the
GPR35 nascent polypeptide and the components of the pro-
karyotic system take place. Radiolabelled intermediates ranged
from 25-65aa (from the PTC to K20), at increasing at intervals
of 10aa. This range allowed us to explore the interactions tak-
ing place both during and after TM1 has traversed the ribo-
some tunnel. In the absence of the cross-linker molecule BS3,
the translated nascent peptides can be seen to increase in size as
they increase in length from 25-65aa (Fig. 2b, e). Weaker
background bands, believed to result from endogenous DNA/
RNA are also visible (Fig. 2b, e). In the presence of BS3, the
different sized peptides can once again be detected; however,
there is also evidence of interactions occurring between the
nascent chain and components of the SRP pathway. The first
evidence of this is when theMK is 35aa from the PTC, placing
it extremely close to the exit site of the ribosome tunnel and
suggesting that the nascent chain is likely to be in an extended
conformation. This band can be immunoprecipitated with an
antibody raised to the uL23 protein and is the first sign of
cross-linking to a protein involved in the targeting of GPR35
(Fig. 2c). The cross-links between the nascent chain and uL23
also exist at intermediates of 45aa and 55aa in length, suggest-
ing the nascent chain may reside in the distal regions of the
tunnel for an extended period. Also between the lengths of 45-
55aa, a higher cross-link appears at approximately 55 kDa and
can again be detected in the 65aa sample (Fig. 2b). These larger
cross-links can be immunoprecipitated by the antibodies raised
to the Ffh protein (Fig. 2d). The results seem to show a sequen-
tial interaction for the nascent chain passing from the uL23 to
Ffh protein, with cross-links weakening in uL23 and strength-
ening in Ffh after approximately 55aa.
We performed simultaneous cross-linking experiments in a
eukaryotic system to test the timing of an interaction between
GPR35 and eukaryotic SRP. Using the Rabbit Reticulocyte
Lysate (RRL) expression system, intermediates of the same
length and range were generated (Fig. 2e), producing results
similar to those seen in the prokaryotic system. In the absence
of BS3, translation product representative of each intermediate
could be detected. Also, present in each sample at approximate-
ly 16 kDa was a double band representative of the protein haem
(found in all RRL samples isolated by centrifugation through a
sucrose cushion) and an unknown band at ~28 kDa. In the
presence of BS3, cross-links between the nascent chain at
lengths 55 and 65aa could be detected with a protein of approx-
imately 50 kDa (Fig. 2e). The bands that appeared in the cross-
linked samples were immunoprecipitated with an antibody
raised to SRP54, indicating an interaction was taking place
between the nascent chain and eukaryotic SRP (Fig. 2f).
Cross-linking to SRP54 at 55aa is in agreement with the results
seen in the prokaryotic system, suggesting the GPR35 signal
anchor encounters SRP as an extended peptide. Prolonged
cross-linking of GPR35 between uL23 and SRP may also sug-
gest the first signs of compaction in TM1; however, this cannot
be certain at this point.
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Hydrophobicity, and not secondary structure,
within the signal anchor drives an interaction
with SRP
It has been suggested that both ∝−helical structure and hy-
drophobicity play a key role in initiating an interaction be-
tween the nascent chain and SRP at the exit tunnel of the
ribosome (Schibich et al. 2016). A number of nascent poly-
peptides have shown the ability to form ∝ − helical structures
upon exiting the ribosome, and SRP can house an ∝−helix of
approximately 10aa in its hydrophobic groove. However,
based on our pegylation and crosslinking assays, this does
not seem to be the case for the first TM domain of GPR35.
Previous results show an extended polypeptide in the exit
tunnel; therefore leading us to hypothesise that its affinity
for SRP was solely driven by hydrophobicity.
To investigate the effect a loss in hydrophobicity within the
signal anchor had on SRP binding, a similar cross-linking
experiment was once again undertaken. Three constructs were
generated to significantly reduce hydrophobicity in the N-
Fig. 2 TM1 of GPR35 binds SRP upon exiting the ribosome ET. (a)
The first 85 residues of human GPR35 are shown with the position of the
single lysine (K20), required for cross-linking with BS3, labelled as
amino acid 1. TM domains 1 and 2 are highlighted using boldface.
Intermediate lengths of GPR35, used for in vitro cross-linking
experiments, are underlined and the length is denoted below in amino
acids (aa). Autoradiographs of radiolabelled translation products
generated from stalled intermediates of between 25 and 65aa in length
can been seen before (-BS3) and after (+BS3) treatment with BS3,
when resolved on a 15% tricine gel. Intermediate length was measured
from the PTC to K20. (b) Intermediate lengths of GPR35 were expressed
in the S-30 transcription/translation system. Prominent cross-links
displaying the correct molecular weight for GPR35-L23 and GPR35-
Ffh complexes have been marked by a and * respectively. Products
of the cross-linking assay in the prokaryotic system were subjected to
immunoprecipitation with (c) anti-uL23 serum, (d) anti-Ffh serum,
showing specific cross-links were occurring between these proteins and
the ribosome bound nascent chain. (e) Similar sized intermediate lengths
of GPR35 were expressed in the eukaryotic Rabbit Reticulocyte Lysate
(RRL) system. Cross-links displaying the correct molecular weight for
GPR35-SRP54 aremarked by a◄. (f) Products of the cross-linking assay
in the eukaryotic system were immunoisolated with an anti-SRP54
serum, which displayed specific cross-links to a number of stalled
intermediates
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terminus (ΔNT), C-terminus (ΔCT) or entire signal anchor
domain (Δ4E) (Fig. 3a). Substitution of leucine to glutamic
acid residues were introduced in order to have the most dra-
matic effect, without altering the entire sequence of the first
TM domain. Substitutions resulting in the Δ4E variant
abolished the hydrophobicity within the signal anchor
(Fig. 3c); however, theΔNTorΔCT variants retained enough
hydrophobicity to be recognised as a TM protein on the DAS
model.
Cross-linking with BS3 was then carried out using the
55aa intermediate (K20 is 55aa from the PTC), as this peptide
length showed cross-linking to uL23, Ffh and SRP54. As
before, the uL23 protein was used as a cross-linking control
in the S-30 expression system and was shown to interact in the
same manner with all four intermediates following immuno-
precipitation (Fig. 4b i). However, differences can be noticed
between the WT and the 3 variants when cross-linked with
both eukaryotic and prokaryotic SRP. In the prokaryotic S-30
system, both the ΔNT and ΔCT intermediates form a much
weaker interaction with Ffh (Fig. 4b ii) and were found to
interact with a lower than 50% affinity compared to the WT
GPR35. Although this is the case, both intermediates are ca-
pable of rescuing the loss of Ffh binding seen with the Δ4E
intermediate (Fig. 4b ii, c ii). When the same experiment was
carried out in the eukaryotic RRL system, a different effect
could be seen when comparing the four intermediates. The
WT intermediate was once again shown to have the strongest
interaction to SRP whereas the Δ4E intermediate, containing
the four leucine to glutamic acid mutations, could not be
cross-linked to SRP54 at all (Fig. 4b iii). However, a notice-
able difference was detected between the binding of SRP54 to
the ΔNT and ΔCT intermediates (Fig. 4b iii). The ΔNT in-
termediate interacts with SRP54 in a manner that is more
representative of the Δ4E intermediate, barely rescuing
cross-linking to SRP at all. The cross-linking efficiency be-
tween the nascent chain and SRP54 is reduced to approxi-
mately 20% (Fig. 4c iii), a much greater effect than the one
that occurred between the same construct and Ffh. The oppo-
site effect occurs between the ΔCT intermediate and SRP54,
with SRP binding approximately 75% of that seen with the
WTconstruct (Fig. 4b iii, c iii). The results highlight a possible
difference between prokaryotic and eukaryotic SRP cross-
linking, potentially alluding to a different mechanism of rec-
ognition or simply a higher level of complexity behind SRP
binding in eukaryotes.
Postranslational targeting and integration of GPR35
Due to the interaction detected between GPR35 and SRP54,
GPR35 was expected to become integrated into the ER mem-
brane via the Sec61 translocon. To ensure successful integra-
tion and correct orientation, digestion and glycosylation ex-
periments were set up. Radiolabelled GPR35 nascent chains
were generated using the RRL in vitro translation system, to
which dog pancreas microsomes (DPMs) were added to pro-
vide an ER membrane component and the end point for
Fig. 3 Substitution of Leucine for Glutamic acid residues severely
reduces the hydrophobicity in transmembrane domain 1 of GPR35.
(a) Substituted Leucine to Glutamic acid residues are highlighted in green
when at the N-terminus of TM domain 1, blue when in the C-terminus
and red when all four exist throughout. The marker lysine (K20) is
marked with by a *. (b) The hydrophobicity of GPR35 WT (black) and
GPR35 Δ4E (red) was calculated using the Dense Alignment Surface
(DAS) method (Cserzö et al. 1997). Four Glutamic acid substitutions at
positions 27, 31, 36 and 40 within GPR35 TM domain 1 (red), reduce the
hydrophobicity below the strict cut-off point (dotted line) set out by the
DASmethod indicating the presence of a TM domain. (c) Substitutions of
Leucine to Glutamic acid at residues 27 and 31 (green), and residues 36
and 40 (blue) reduce the hydrophobicity in the N-terminus and C-
terminus of GPR35 TM domain 1 respectively
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GPR35 insertion. The initial experiment to test the success of
GPR35 insertion into the ER membrane was carried out using
a digestion assay. This relied on the protease activity of pro-
teinase K (PK) to assess whether or not integrated domains of
mature GPR35 had gained protection from the membrane bi-
layer (Fig. 5a i). In the presence of DPMs, the translated full
length GPR35 can be detected at approximately 30 kDa, indi-
cating correct insertion (Fig. 5a ii). In the absence of DPMs no
full-length GPR35 was detected, indicating that GPR35 only
isolates with the membrane. The insertion of mature GPR35
was confirmed upon the addition of PK at which point
the 30 kDa band disappeared and was replaced by
bands at ~7 kDa. These bands represent TM fragments
of the GPR35 that have been protected from PK degra-
dation by the lipid bilayer. Insertion of GPR35 into the
membrane was further confirmed by disrupting the per-
meability of the bilayer with detergent (Fig. 5a ii). The
bands present in the sample containing DPMs could no
longer be detected because disruption of the membrane
allows for the degradation of the full GPR35 protein.
Although the digestion assay confirms integration into
the membrane, at no point was N-linked glycosylation
of full length GPR35 detected. A native glycosylation
site on the GPCR N-terminus should interact with the
oligosaccharyl-transferase (OST) complex close to the
Sec61 translocon upon integration, providing informa-
tion on whether GPR35 has taken up the correct orien-
tation. Therefore, the results indicate that GPR35 can be
successfully inserted into DPMs but the orientation of
the full-length protein is unknown.
Fig. 4 Cross-linking assay of GPR35 hydrophobic mutants reduce
binding to prokaryotic and eukaryotic SRP. (a) Autoradiographs of
radiolabelled translation products of GPR35 hydrophobic mutants, at a
length of 55 amino acids, can been seen before (-BS3) and after (+BS3)
treatment with BS3 when resolved on a 15% SDS-PAGE gel. Prominent
cross-links displaying the correct molecular weight for GPR35-SRP54
complexes have been marked with a *. (b) Cross-linking samples were
immunoisolated with, (i) anti-SRP54 serum, (ii) anti-Ffh serum or (iii)
anti-L23 serum. SDS-PAGE gels used for autoradiographs were
rehydrated and stained with Coomassie Blue, which provided a loading
control for quantification of cross-linking (iv). (c) Bar graphs show the
average percentage cross-linking to (i) SRP54 (ii) Ffh, or (iii)
L23 for individual intermediates. Immunoprecipitation bands
were quantified using Image J software. All percentage cross-
linking values were calculated using [Immunoprecipitation
product/Coomassie loading control] and adjusted for background.
Average percentage cross-linking is calculated from an n = 3
replicates. Error bars are ± SD groups were compared using
one-way ANOVA with Tukey’s post hoc comparisons. *p < 0.05,
**p < 0.005, ***p < 0.001
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To further investigate the orientation of GPR35 post inser-
tion, a glycosylation assay was designed. On this occasion an
engineered glycosylation site was placed at the C-
terminal end of an 182aa intermediate of GPR35
(Fig. 5b i). This glycosylation site was incorporated into
the DNA template through PCR, at the sequence
encoding for extracellular loop 2 (positioned on the lu-
minal side of the ER of the mature GPR35) extending
the protein by 18aa. This extension placed the glycosyl-
ation site 16aa downstream from TM4 and theoretically
in range of the OST complex (Fig. 5b i). The template
lacks a stop codon, generating stalled ribosome bound
nascent chains that are only released by the addition of
RNaseA and EDTA to the translation mix. This selective re-
lease from the ribosome enables the comparison between the
glycosylated and unglycosylated peptides, to confirm that
GPR35 is inserted in the correct orientation.
The results of this assay show convincingly that GPR35 is
capable of inserting into DPMs with the correct orientation
(Fig. 5b ii). Upon translation and isolation of the membrane
integrated 182aa intermediate, a single band could be
detected at ~16 kDa representing an unglycosylated ri-
bosome bound peptide. Upon addition of RNaseA and
EDTA to the translation mix, the peptidyl-tRNA bond
was broken and the ribosomal subunits removed,
allowing for the release of the GPR35 C-terminus.
Subsequent translocation of the C-terminus produced
two bands when analysed by gel electrophoresis, one
representing the 182aa intermediate and a second higher
band representative of the glycosylated product. This
suggests that GPR35 is in the correct orientation, there-
fore allowing us to carry out further structural evalua-
tions on its signal anchor domain as it becomes inserted
into the membrane.
Fig. 5 Digestion and glycosylation assays indicate hydrophobicity of
the transmembrane domain 1 in GPR35 is required for membrane
insertion. (a) (i)A schematic diagram indicating how GPR35 is correctly
orientated in the ER membrane. The seven transmembrane domain
protein is inserted N-terminally, so that the N-terminus it is exposed to
the endoplasmic reticulum (ER) lumen. (ii)Radiolabelled full-length (FL)
GPR35 was targeted to dog pancreas microsomes (DPMs) that were
added to the RRL translation mix. DPMs were washed with KOAc to
ensure GPR35 was fully inserted and not just associated with the lipid
bilayer. Digestion assays used proteinase K (PK) and RnaseA (R),
assessed if GPR35 was successfully inserted into DPMs. Successful
insertion of FL GPR35 should provide protection of TM domains and
luminal loop regions. The addition of the detergent Triton X-100 (Triton
X) will permeabilize the DPM bilayer enabling digestion of entire GPR35
protein. GPR35 cannot be isolated in samples lacking DPMs. (b) (i)
Schematic diagram shows how a GPR35 intermediate of 182aa length
should be orientated in the DPM bilayer. A synthetic glycosylation site
introduced at the C-terminus should determine orientation. (ii) A
glycosylation assay to assess if the GPR35 182aa intermediate is
correctly orientated in the membrane. Selective release and
glycosylation of the 182aa intermediate by RNaseA, shows GPR35 is
orientated correctly in DPMs. The glycoslyated translation product is
indicated by a *. (c) (i) Glycosylation assay to assess translocation of
the GPR35 TM1 domain hydrophobicity mutants. Ribosomes displaying
radiolabelled N-terminal intermediates of GPR35 at lengths of 75
amino acids. Translation product and glycoslyated translation product
are indicated by 0 and 1 respectively, with the presence of the
background haem band marked with a <. Products were resolved on a
15% Tricine gel. (ii) Glycosylation results were quantified using Image J
software. All percentage glycosylation values were calculated using
[glycosylated product/ total translation product] and adjusted for
background. Average percentage of glycosylation is calculated from an
n = 3. Error bars indicate SD and groups were compared using one-way
ANOVA with Tukey’s post hoc comparisons. *p < 0.05, **p < 0.005,
***p < 0.001. (iii) Model showing the approximate extension length
required to span the ribosome-Sec complex, as estimated from the
glycosylation data, with the presence of an α-helical TM domain within
the Sec channel
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Collectively these results suggest that in this system
GPR35 is capable of making its way successfully to the mem-
brane bilayer, where it correctly orientates. This integration
process is heavily linked to the native hydrophobicity within
the first TM domain, which aids the co-translational targeting
process carried out by SRP.
Hydrophobicity in the signal anchor of GPR35 plays
a key role in translocation
Previous results suggest that hydrophobicity within the signal
anchor domain plays a key role in targeting GPR35 to the
Sec61 translocon. We now would like to address whether
altering the hydrophobicity within the signal anchor affects
the translocation and integration processes. To determine this,
we once again used the constructs ΔNT, ΔCT and Δ4E, and
quantify how they integrate into the membrane of DPMs. To
do this, we generated radiolabelled intermediates (75aa in
length) long enough to interact with the OST found adjacent
to the Sec61 translocon and assessed N-linked glycosylation
at the native site at the N-terminus of GPR35 (Fig. 5c iii). In
the absence of DPMs, one band representative of the transla-
tion band exists (Fig. 5c i). Upon the addition of DPMs to the
RRL translation reaction, the GPR35 WT intermediate, as
expected, becomes targeted and successfully inserted.
Approximately half the translation product shows a shift in
MW from ~7 to ~14 kDa, representative of glycosylation at
the N-terminal glycosylation site. To ensure the higher MW
band was glycosylated translation product, the DPMs were
incubated with the enzyme endoglycosidase H (Endo H),
which is capable of removing sugar group generated from a
glycosylation event. In the presence of Endo H, the higher
MW bands associated with glycosylation were successfully
removed (Fig. 5c i). A similar assay was carried out using
the ΔNT and ΔCT constructs, where both intermediates
showed a reduction in translocated product in comparison to
the WT GPR35 intermediate, which may have been represen-
tative of a loss of interaction between the nascent chain and
SRP, as seen in the cross-linking results (Fig. 4b, c). Generally,
the effect on translocation in the ΔNT intermediate was sig-
nificantly greater when compared to the WT intermediate,
than what was seen in the ΔCT intermediate (Fig. 5c ii).
Finally, the Δ4E intermediate showed extremely low levels
of the glycosylation product being produced when compared
to each of the other intermediates (Fig. 5c i, c ii). This would
suggest that the N-terminus of the Δ4E intermediate was un-
successfully translocated across the ER membrane due to of a
loss in hydrophobicity, leading to poor SRP targeting or poor
insertion into the DPM membrane.
This result highlights the importance of hydrophobicity not
only for an interaction with SRP, but for downstream events
such as translocon interactions and lipid bilayer integration.
Remaining hydrophobicity within the ΔNT and ΔCT
intermediates, although significantly reduced when compared
to the WT intermediate, enables translocation and integration
into the ER membrane. Reducing the hydrophobicity below
the level of a recognisable TM domain all but abolishes cor-
rect integration by Sec61.
Assessing the secondary structure of GRP35
transmembrane domain 1 during translocation
Finally, as we suspect that the signal anchor domain of GPR35
remains in an extended conformation during membrane
targeting by SRP, it is expected that the α-helical structure
must form before release from the translocon. Therefore, we
expect a conformational change within the GPR35 signal an-
chor during insertion into the Sec61 translocon. To assess this
conformational change, we can use a similar assay used by
(Whitley et al. 1996), where the length of the glycosylated
nascent chain indicates the presence of secondary structure.
In an extended conformation, with each residue contributing
~3.4 Å to the length of the nascent chain, roughly 65aa should
be required to span the distance from the PTC to the OST. The
result of folding within the signal anchor, whilst inside the
Sec61 translocon, will increase the required peptide length
to 75aa (Fig. 5c iii). For this experiment a construct with a
second glycosylation site was designed to avoid interference
with a previously described background band, believed to be
haem, which runs at the same size as some of the smaller
glycosylated intermediates. In the absence of DPMs from
the RRL translation system, a band correlating to the size of
each unglycosylated intermediate could be detected. Also
present was the background haem band (~16 kDa) seen pre-
viously arise upon isolation of RNCs without DPMs present.
Upon the addition of DPMs, the appearance of two bands of
increased molecular weight (MW) could be detected along
with the unglycosylated intermediate (Fig. 6a). The two bands
of increased MW were the result of a single or double glyco-
sylation event taking place at the N-terminus of GPR35 inter-
mediates. The 65aa intermediate shows no sign of glycosyla-
tion at either glycosylation site, suggesting that it is not long
enough at this point to interact with the OST complex.
Although the first glycosylation site within this intermediate
is 70aa from the PTC and theoretically should be capable of
low levels of glycosylation, there is none to be detected. This
could indicate that this site in particular does not become
glycosylated efficiently or may not be recognised by the
OST due to its close proximity to the start codon. In the
70aa intermediate however, signs of weak glycosylation can
be detected at both sites, suggesting that ~70 residues are
required for glycosylation to occur. Glycosylation then ap-
pears to occur at increased levels in the 75aa intermediate,
suggesting it is at an optimum length for interaction with the
OST; this level of glycosylation was maintained throughout
the longer peptide lengths (Fig. 6b). To ensure the two higher
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MW bands were a result of glycosylation, the isolated DPMs
were treated with the enzyme EndoH. Upon addition of the
enzyme, the existence of the two higher MW bands disappear,
hence confirming that they result from glycosylation of the
native intermediate (Fig. 6a and b). Collectively, these results
indicate that a folding event has taken place in the signal
anchor domain, during point of interaction with SRP and in-
sertion into the Sec61 translocon.
The introduction of two proline residues at positions 31 and
40 within the TM1 domain of GPR35, further strengthened
the argument for the formation of secondary structure within
the translocon (Fig. 6c). The 65aa intermediate, previously
incapable of becoming glycosylated, showed evidence of
two glycosylation bands when proline residues were intro-
duced into the first TM domain of GPR35. This suggests that
the TM domain is unstructured and remains in an extended
conformation, hence interacting with the OST machinery.
Glycosylation as a marker for the presence of secondary
structure in translocating intermediates of GPR35 was capable
of determining that the N-terminus and specifically the first
TM domain forms a compacted structure in the Sec61
translocon. The lack of glycosylation products at 65aa from
the PTC and the presence of glycosylated intermediates at
70aa, and increasingly at 75aa, indicate the presence of a
helix-like domain during translocation. At this point we are
unable to confirm whether it is due to an interaction with SRP
or the translocation events that begins folding of TM1. In
either case, it is an essential event in the biogenesis of
GPR35, preparing it for integration into the membrane.
Discussion
Transmembrane domain biogenesis has been well studied in
the last decade, yet precise data on where and why such an
event takes place is poorly understood. Many IMPs are known
to be inserted into their respective membranes co-
translationally and for this to occur correctly, insertion com-
petency must be maintained. Several research groups have
highlighted key steps between translation and integration
where an IMP can begin to form secondary and even tertiary
structure. In this study, we have assessed the conformational
changes occurring in the signal anchor domain of a GPCR,
GPR35, during the early stages of membrane protein biogen-
esis. GPCRs are one of the largest and most widely studied
family of membrane proteins; however, little research has fo-
cused on the folding of their TM domains prior to membrane
insertion. Our work indicates that unlike many IMPs studied
to date, the first TM domain of GPR35 exists in an extended
state until entry into the Sec translocon. In vitro pegylation
assays were the first to indicate that the nascent polypeptide,
containing the GPR35 signal anchor, could traverse and exit
the tunnel in a relaxed conformation. Cross-linking data con-
firmed the lack of secondary structure within the first TM
domain, as nascent chain lengths of between 35aa and 45aa
could interact with ribosomal protein uL23 and SRP/Ffh re-
spectively. Interestingly, the lack of secondary structure in the
signal anchor had no ill effects on the interaction or co-
translational targeting of the nascent polypeptide by SRP.
Mutations in the TM domain, which decreased the hydropho-
bicity, resulted in a loss of interaction between the nascent
chain and SRP, and thus affected integration of the signal
anchor into the ER. This seemed to suggest that intrinsic
Fig. 6 Analysis of GPR35 glycosylation to detect the formation of
secondary structure in the Sec61 translocon. Autoradiographs of
radiolabelled translation products of GPR35-gly construct. Intermediate
lengths ranging from 65-75aa (a) and 80-100aa (b) of GPR35 were
expressed in an in vitro RRL translation reaction. Reactions were split into
three, with one third being incubated without DPMs, another being incu-
bated in the presence of DPMs and the final third being incubated in the
presence of DPMs and Endo H. Autoradiographs indicate the presence of
an unglycosylated translation product (0), a singly glycosylated translation
product (1) and a doubly glycosylated product (2). In addition, the presence
of a background band at approximately 16 kDa, which is representative of
haem, is indicated by a <. (c) Two leucine to proline substitutions at posi-
tions 34 and 40were introduced into the first TMdomain of the GPR35-gly
construct, generating GPR35-2P (2P). The presence of two prolines act as a
helix breaker and generating an extended intermediate, which acted as a
negative control for glycosylation. Glycosylation of the 65aa GPR35-2P
confirms the presence of a helix in TM domain 1
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hydrophobicity within the TM domain and not secondary
structure was the driving force for entering the co-
translational targeting pathway. Finally, a glycosylation assay
was set up to assess the folding profile of the signal anchor
upon entry into the Sec61 translocon. This is the first point at
which the TM domain of the nascent GPCR polypeptide re-
sembled an α-helical peptide.
Interestingly, the folding profile of this eukaryotic protein
is unlike much of what has been observed previously with
other TM domains or signal peptides whilst traversing the
ribosome tunnel. To date a number of studies have shown
TM domains have a high propensity for forming secondary
and even tertiary structure before exiting the ribosome.
However, here we present an integral domain of a eukaryotic
membrane protein which remains extended until the point in
which it is inserted into the Sec61 translocon. A number of
studies have highlighted the role played by the ribosome tun-
nel in aiding the formation of secondary structure within TM
segments of a translating nascent chain (Lu and Deutsch
2005a; Robinson et al. 2012; Woolhead et al. 2004). In par-
ticular, several studies have provided evidence for preferred
‘folding zones’ within the tunnel where compaction of the
nascent chain takes place. A number of experiments suggest
that the upper tunnel, near the PTC, is one such region where
folding can occur. Ribosomal proteins uL4 and uL22, found in
the mid-tunnel, are believed to either play a role in stabilizing
a structure that had previously formed in the upper tunnel or
even aid compaction within the nascent chain itself. Our re-
sults from both the pegylation and cross-linking assays sug-
gest that compaction of GPR35 in the upper tunnel is highly
unlikely, as nascent peptides can be both pegylated at ~30aa
and cross-linked to uL23 as early as 25aa from the PTC.
Cross-links identify the close proximity of the nascent chain
to the ribosomal protein uL23, located at the base of the large
subunit. It is therefore unlikely that a peptide of this length
could become pegylated out with the tunnel, or interact with a
protein at the exit port of the ribosome and contain secondary
structure. However, in the last decade, it is the most distal
regions of the tunnel where the greatest wealth of structural
data within nascent peptides has appeared. This region has
been the most frequently described ‘folding zone’ for second-
ary structure in TM domains of IMPs and the only region
described for the formation of tertiary structure, such a β-
hairpins or the complete formation of small proteins (Marino
et al. 2016; Nilsson et al. 2015; Tu et al. 2014). In this study,
we can track the TM domain as it moves through the tunnel
and by varying the length of intermediates we can detect
whether folding has taken place. Again the interaction with
uL23 at intermediate lengths between 25-35aa suggests, even
in the lower regions of the tunnel, compaction has not oc-
curred. At this point the entire TM1 domain would be synthe-
sised and shows little evidence of secondary structure forma-
tion during the early stages of synthesis. uL23 is known to
play an important role in the targeting of membrane proteins,
with its loop domain acting as a sensor in the recruitment of
SRP.
As the peptide grows in length, an interaction with SRP can
be identified. Again, the nascent chain appears to interact with
SRPwhilst in an extended conformation (cross-links both Ffh/
SRP54 at ~45aa in length). At this intermediate length, for an
interaction to be occurring between the nascent chain and
SRP, the signal anchor would have traversed the tunnel and
be located in the vestibule, with its N-terminus protruding
from the exit port. Although, the GPR35 nascent chain meets
with SRP in such an extended conformation, we are uncertain
whether the entire TM domain remains so. Structural data
analysing the interaction between a signal sequence and the
M domain of SRP suggests 10 extended residues would be
unlikely to fit in the hydrophobic groove (Janda et al. 2010).
To date, most structural data suggests that the binding groove
of SRP, which interacts directly with the nascent chain as it
exits the ribosome, is likely to house an α-helical peptide of
approximately 10aa in length (Halic et al. 2006; Janda et al.
2010; Keenan et al. 1998; Voorhees and Hegde 2015).
Therefore, based on the structure of SRP, a compacted portion
of N-terminus in the first TM of GPR35 would be more
favourable. This being said, our study shows that it may be
in fact hydrophobicity within the signal anchor that drives an
SRP interaction, limiting structure to a minor role. By
substituting 2 leucine for aspartic acid residues, at either the
N-terminal or C-terminal end of the TM domain, the interac-
tion between nascent chain and SRP was dramatically re-
duced. The introduction of all four leucine residues within
the TM domain abolished the interaction completely. As a
number of studies have previously suggested, hydrophobicity
within a signal peptide or anchor domain is essential for an
interaction with SRP and in the case of GPR35 it may be the
driving force for initialising the co-translational targeting
pathway. Furthermore, we observe an adverse effect on the
integration of the signal peptide when the hydrophobicity is
dramatically altered. Altering the hydrophobicity of the signal
anchor domain results in a failure to initiate targeting to the
ER, hence compromising the ability of the nascent polypep-
tide to become translocated and integrated into the membrane.
Whether the loss of a hydrophobic TM segment impacts on
the recognition of the nascent by ribosomal proteins or direct
impacts the interaction with SRP it is unknown. However,
sensing of a hydrophobic stretch in a nascent polypetide by
proteins within the ribosomal tunnel has been shown to play a
highly important role in the co-translational targeting pathway.
This work proposes that up until the point at which the first
TM domain reaches the Sec61 translocon, the nascent GPR35
signal anchor remains extended or at best loosely folded.
Although this is the case, ultimately it is vital that the signal
anchor assumes an α-helical conformation before becoming
integrated into the ER membrane. The translocon, through
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which the nascent polypeptide will pass, has been shown to
provide a suitable environment for a compacted nascent chain,
such as an α-helix. Indeed, a number of studies have shown
that the Sec61 translocon is known to favour compacted or α-
helical peptides (Hessa et al. 2005). Following a well-
established method of studying helical domains in the Sec61
translocon, we see the GPR35 signal anchor domain change
from an extended conformation to a compacted peptide. This
suggests that the environment provided by the translocon is
sufficient to generate a conformational change within the first
TM domain, allowing it to be successfully integrated into the
ER membrane. This work presents another example of the
folding potential within a nascent peptide provided it is situ-
ated in the correct environment.
Helix formation within the TM domains of an IMP is a
process that is fundamental for ensuring that the correct bio-
genesis of the protein is acquired. The ability for such proteins
to obtain their structure as they progress through the co-
translational targeting and integration cycle undoubtedly plays
a role in deciding their fate. Our findings show that a TM
domain, in a protein as integral as a GPCR, can remain in a
relatively unfolded state until entry into the translocon. The
ribosome tunnel has been increasingly thought of as an induc-
er and director of protein folding and targeting. However, the
results shown here with regard to the signal anchor of GPR35
may suggest that there is a subset of membrane proteins that
can remain unfolded until the point of membrane insertion.
Materials and methods
Plasmid construction
All plasmids used in this study are listed in Table S1. For
transcription/translation experiments, intermediates of
GPR35 were amplified from the construct pTrc99aGPR35
(pGPR35) for prokaryotic assays and the construct
pcDNA3.1GPR35 (pcGPR35) for eukaryotic assays. For ex-
periments using the E.coli S-30 extract system, GPR35 was
placed under the control of a trc promoter and when using the
Wheat Germ (WG) or Rabbit Reticulocyte Lysate (RRL) sys-
tem, GPR35 was placed under the control of a T7 promoter.
For pegylation experiments, a C8A mutation was carried out
to remove a native cysteine residue. A marker cysteine (MC)
residue, essential in the pegylation process, was introduced
10aa upstream of the signal anchor domain by a W15C muta-
tion to yield pGPR35C (pTrc99a) and pcGPR35C
(pcDNA3.1). Mutations that affected the properties of the first
TM domain were incorporated into pGPR35 and pcGPR35;
L27E, L31E, L34E and L40 resulted in pGPR35Δ4E; L27E
and L31E resulted in pGPR35ΔNT; L34E and L40E resulted
in pGPR35ΔCT. For experiments requiring glycosylation of
pcGPR35, a single native glycosylation site was used or a
second site was engineered by introducing an S residue be-
tween N6 and T7. This yielded the construct pcGPR35-gly.
Mutations affecting secondary structure of the signal anchor
domain were incorporated into pcGPR35-gly; L31P and L40P
resulted in pGPR35-gly2P. Amplification reactions were car-
ried out using an ExTaq PCR kit (TaKaRa), and site-directed
mutagenesis was carried out using the QuikChange system
(Stratagene).
RNC preparation
S-30 extract was prepared from strain C41 essentially as de-
scribed previously (Woolhead et al. 2006). Linear DNA was
amplified from the appropriate constructs using an ExTaq
PCR kit (TaKaRa). In these reactions, the 5′ primer was locat-
ed upstream of either the trc promoter in pTrc99a (5′-
CTGAAATGAGCTGTTGACAATTAATCATCCGG-3′) or
the T7 promoter of pcDNA3.1 (5′-TAATACGACTCAC-
TATAGGG-3′). The various 3′ reverse primers used, which
are described in the Table S2, amplified internally from the
GPR35 gene to produce DNA intermediates of the required
length, lacking stop codons.
Purified amplified DNA was used in the S-30 coupled
transcription/translation system; these reactions were per-
formed in varying volumes principally as described previous-
ly for S-30 reactions. Briefly, a typical 50 μL reaction
contained 1 μg DNA, 20 μL premix, 5 μL 1 mM L-amino
acids (minus methionine), 15 μL S-30 extract, 20 μCi [35S]
methionine, and an antisense oligonucleotide to SsrA at a
concentration of 200 ng/mL. Reactions were incubated at
37 °C for 30 min and chilled on ice for 5 min.
For WG and RRL systems, in vitro transcription with T7
RNA polymerase was carried out on amplified DNA samples
at 37 °C for 2 h. Purified RNA was used to generate [S35]
methionine radiolabelled proteins in vitro; reactions were per-
formed in varying volumes principally as specified by
Promega Protocol and Application guide.
Pegylation assays
As previously described (Lu and Deutsch 2005a), RNCs were
pelleted through a sucrose cushion (100 μL; 0.5 M sucrose,
100 mM KCl, 5 mMMgCl2, 50 mM HEPES, 1 mM DTT
(pH 7.5)) for 6 min at 436,000 g at 4 °C in a Beckman
TLA-100 rotor. The pellet was resuspended in 30 μL of buffer
(100 mM NaCl, 5 mM Mg2+, 20 mM HEPES, 50 mM DTT
(pH 7.2)) by pipetting gently, avoiding the formation of bub-
bles. An equal volume of buffer containing 2 mM PEG-MAL
was added (final PEG-MAL concentration was 1 mM) and
incubated on ice for 2 h. The reaction was terminated by
adding DDT (100 mM) and incubating at room temperature
for 10 min. To precipitate the ribosome nascent chains, add
600 μL NaOAc (0.5 M (pH 4.7)) and 250 μL 2% cetyl
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trimethylammonium bromide (CTAB). The pellets were aspi-
rated in 15 μL RNAaseA (1 mg/mL) to digest tRNA. Samples
were heated in 2X sample buffer (4% SDS, 20% Glycerol,
0.12 M Tris pH 6.8, and 10% BME) at 95 °C for 5 min for
analysis through Tricine SDS-PAGE.
Chemical cross-linking and immunoprecipitation
Translation reactions (100 μL) were carried out as previously
described to generate nascent peptides of desired lengths. A
7 μL portion of the reaction is overlayed onto a 50 μL sucrose
cushion (tube A) while the remainder is overlayed onto a
100 μL sucrose cushion (tube B). RNCs were pelleted in a
Beckman TLA-100 rotor for 6 min at 436,000 g at 4 °C to
pellet the ribosome bound nascent chain. Pellet A was resus-
pended in 8 μL of RNC buffer, 100 μg/mL RNase A and
5 mM EDTA at incubated at 26 °C for 10 min. The sample
was the heated in 2 X sample buffer at 95 °C for 5 min. Pellet
B was resuspended in 88 μL of BS3 buffer (RNC buffer and
1 mM BS3) and incubated on ice for 2 h. The reactions are
quenched on the addition of 5 ml of 1 M Tris pH 8.0 and
incubated at 20 °C for 15 min. 7 μL of sample is added to
100 μg/ mL RNase A and 5 mM EDTA at incubated at 26 °C
for 10 min and heated in 2 X sample buffer at 95 °C for 5 min.
The remainder of the samples were TCA precipitated and used
for immunoprecipitations with polyclonal rabbit antisera gen-
erated against the L23, Ffh and SRP54 peptides. All samples
were resolved using Tricine or Tris-Bis SDS-PAGE gels.
Insertion of GPR35 into dog pancreas microsomes
GPR35 intermediates produced through the eukaryotic RRL
system were incubated in the presence of dog pancreas micro-
somes (DPMs) (80 equivalents/ml). The reactions were incu-
bated at 30 °C for 30min before ultracentrifugation for 30min
at 434,500 g, 4 °C to pellet the DPMs. The pellets were re-
suspended in sample buffer and analysed through tricine
SDS–PAGE and autoradiography. For digestion assays the
pellets were washed with 3 M potassium acetate (KOAc)
and repelleted before resuspension in 20 mM Hepes pH 7.4.
PK was added at a concentration of 0.2 mg/ml in the presence
or absence of 1% triton X-100.
Endoglycosidase H treatment
Intermediates inserted into isolated DPMs were denatured in
glycoprotein denaturing buffer (0.5% SDS and 40 mM DTT)
for 30 min at 94 °C. The reaction was incubated at 4 °C for
5 min before the addition of 1x Glyco buffer (50 mM NaOAc
pH 6), 5 μL H2O and 5000 units of Endo H enzyme, which
was then incubated at 37 °C for 30 min. Samples were heated
in 2 X sample buffer at 95 °C for 5 min for analysis through
Tricine SDS-PAGE.
Sample analysis
Samples were heated in 2 X sample buffer (4% SDS, 20%
Glycerol, 0.12 M Tris pH 6.8, and 10% BME) at 95 °C for
5 min for analysis through Tricine or Tris/Bis SDS-PAGE.
The gels were fixed and dried before being exposed to
Kodak X-AR film for visualization, and were developed using
the X-omat 2000.
Acknowledgements The authors wish to thank Prof. Graeme Milligan
for providing the original GPR35 construct, Dr. Harris Bernstein for the
L23 and Ffh antibodies and Prof. Neil Bulleid for the SRP54 antibody.
We also thank Dr. Philip Robinson for his helpful discussion and review
of the manuscript.
Funding JC was a recipient of an EPSRC DTP studentship. No addi-
tional grant from any funding agency in the public, commercial or not-
for-profit sectors was used to fund this research.
Compliance with ethical standards
Competing interests No competing interests declared.
Abbreviations IMPs, Integral membrane proteins; TM, transmembrane;
PTC, peptidyl transferase centre; SRP, signal recognition particle; ER,
endoplasmic reticulum; aa, amino acid; MC, marker cysteine; PEG-
MAL, methoxypolyethylene glycol maleimide; MK, marker lysine;
RRL, rabbit reticulocyte lysate; WT, wild type; NT, N-terminal;
CT, C-terminal; OST, oligosacchary-ltransferase; DPMs, dog pancreas
microsomes; Endo H, Endoglycosidase H
Open Access This article is distributed under the terms of the Creative
Commons At t r ibut ion 4 .0 In te rna t ional License (h t tp : / /
creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided you give
appropriate credit to the original author(s) and the source, provide a link
to the Creative Commons license, and indicate if changes were made.
Publisher’s note Springer Nature remains neutral with regard to jurisdic-
tional claims in published maps and institutional affiliations.
References
Ban N, Nissen P, Hansen J, Moore PB, Steitz TA (2000) The complete
atomic structure of the large ribosomal subunit at 2.4 A resolution.
Science 289:905–920
Bhushan S, Gartmann M, Halic M, Armache J-P, Jarasch A, Mielke T,
Berninghausen O, Wilson DN, Beckmann R (2010) Alpha-helical
nascent polypeptide chains visualized within distinct regions of the
ribosomal exit tunnel. Nat Struct Mol Biol 17:313–317
Cserzö M, Wallin E, Simon I, von Heijne G, Elofsson A (1997)
Prediction of transmembrane alpha-helices in prokaryotic mem-
brane proteins: the dense alignment surface method. Protein Eng
10:673–676
Gao Y, Zhang Q, LangY, Liu Y, DongX, Chen Z, TianW, Tang J,WuW,
Tong Y, Chen Z (2017) Human apo-SRP72 and SRP68/72 complex
structures reveal the molecular basis of protein translocation. J Mol
Cell Biol 9:220–230
J Bioenerg Biomembr (2019) 51:137–150 149
Goder V, Spiess M (2003) Molecular mechanism of signal sequence
orientation in the endoplasmic reticulum. EMBO J 22:3645–3653
Hainzl T, Huang S, Meriläinen G, Brännström K, Sauer-Eriksson AE
(2011) Structural basis of signal-sequence recognition by the signal
recognition particle. Nat Struct Mol Biol 18:389–391
Halic M, Blau M, Becker T, Mielke T, Pool MR, Wild K, Sinning I,
Beckmann R (2006) Following the signal sequence from ribosomal
tunnel exit to signal recognition particle. Nature 444:507–511
Heinrich SU, Mothes W, Brunner J, Rapoport TA (2000) The Sec61p
complex mediates the integration of a membrane protein by
allowing lipid partitioning of the transmembrane domain. Cell
102:233–244
Hessa T, KimH, Bihlmaier K, Lundin C, Boekel J, Andersson H, Nilsson
I, White SH, von Heijne G (2005) Recognition of transmem-
brane helices by the endoplasmic reticulum translocon.
Nature 433:377–381
Holtkamp W, Kokic Gm, Jager M, Mittelstaet J, Komar AA, Rodnina
MV (2015) Cotranslational protein folding on the ribosome moni-
tored in real time. Science 350:1104–1107
Janda CY, Li J, Oubridge C, Hernandez H, Robinson CV, Nagai K (2010)
Recognition of a signal peptide by the signal recognition particle.
Nature 465:507–510
Keenan RJ, Freymann DM,Walter P, Stroud RM (1998) Crystal structure
of the signal sequence binding subunit of the signal recognition
particle. Cell 94:181–191
Kobayashi K, Jomaa A, Lee JH, Chandrasekar S, Boehringer D, Shan
SO, Ban N (2018) Structure of a prehandover mammalian ribosomal
SRP·SRP receptor targeting complex. Science 360:323–327
Lee JH, Chandrasekar S, Chung S, Hwang Fu Y-H, Liu D,Weiss S, Shan
S (2018) Sequential activation of human signal recognition particle
by the ribosome and signal sequence drives efficient protein
targeting. PNAS 115:5487–5496
Lu J, Deutsch C (2005a) Secondary structure formation of a transmem-
brane segment in Kv channels. Biochemistry 44:8230–8243
Lu J, Deutsch C (2005b) Folding zones inside the ribosomal exit tunnel.
Nat Struct Mol Biol 12:1123–1129
Lu J, Deutsch C (2008) Electrostatics in the ribosomal tunnel modulate
chain elongation rates. J Mol Biol 384:73–86
Marino J, Von Heijne G, Beckmann R (2016) Small protein domains fold
inside the ribosome exit tunnel. FEBS Lett 590:655–660
McCormick PJ, Miao Y, Shao Y, Lin J, Johnson AE (2003)
Cotranslational protein integration into the ER membrane is medi-
ated by the binding of nascent chains to translocon proteins. Mol
Cell 12:329–341
Nilsson OB, Hedman R, Marino J, Wickles S, Bischoff L, Johansson M,
Müller-Lucks A, Trovato F, Puglisi JD, O’Brien EP, Beckmann R,
von Heijne G (2015) Cotranslational protein folding inside the ribo-
some exit tunnel. Cell Rep 12:1533–1540
Ortenberg R, Mevarech M (2000) Evidence for post-translational mem-
brane insertion of the integral membrane protein bacterioopsin
expressed in the heterologous halophilic archaeon Haloferax
volcanii. J Biol Chem 275:22839–22846
Plath K, Mothes W, Wilkinson BM, Stirling CJ, Rapoport TA (1998)
Signal sequence recognition in posttranslational protein transport
across the yeast ER membrane. Cell 94:795–807
Robinson PJ, Findlay JE, Woolhead CA (2012) Compaction of a pro-
karyotic signal-anchor transmembrane domain begins within the
ribosome tunnel and is stabilized by SRP during targeting. J Mol
Biol 423:600–612
Sadlish H, Pitonzo D, Johnson AE, SkachWR (2005) Sequential triage of
transmembrane segments by Sec61a during biogenesis of a native
multispanning membrane protein. Nat Struct Mol Biol 12:870–878
Schibich D, Gloge F, Pöhner I, Björkholm P, Wade RC, Von Heijne G,
Bukau B, Kramer G (2016) Global profiling of SRP interaction with
nascent polypeptides. Nature 536:219–223
ThommenM, HoltkampW, Rodnina MV (2017) Co-translational protein
folding: progress and methods. Curr Opin Struct Biol 42:83–89
Tu L, Khanna P, Deutsch C (2014) Transmembrane segments form ter-
tiary hairpins in the folding vestibule of the ribosome. J Mol Biol
426:185–198
Van Den Berg B, Clemons WM, Collinson I, Modis Y, Hartmann E,
Harrison SC, Rapoport TA (2004) X-ray structure of a protein-
conducting channel. Nature 427:36–44
Van Der Laan M, Bechduft P, Kol S, Nouwen N, Driessen AJM (2004)
F1F0ATP synthase subunit c is a substrate of the novel YidC path-
way for membrane protein biogenesis. J Cell Biol 165(2):213–222
Voorhees RM, Hegde RS (2015) Structures of the scanning and engaged
states of the mammalian SRP-ribosome complex. Elife 4:1–21
Voorhees RM, Hegde RS (2016) Structure of the Sec61 channel opened
by a signal sequence. Science 351:88–89
Voorhees RM, Fernández IS, Scheres SHW, Hegde RS (2014) Structure
of the mammalian ribosome-Sec61 complex to 3.4 Å resolution.
Cell 157:1632–1643
Voss NR, Gerstein M, Steitz TA, Moore PB (2006) The geometry of the
ribosomal polypeptide exit tunnel. J Mol Biol 360:893–906
Whitley P, Nilsson I, Von Heijne G (1996) A nascent secretory protein
may traverse the ribosome/endoplasmic reticulum translocase com-
plex as an extended chain. J Biol Chem 271:6241–6244
Woolhead CA, McCormick PJ, Johnson AE (2004) Nascent membrane
and secretory proteins differ in FRET-detected folding far
inside the ribosome and in their exposure to ribosomal pro-
teins. Cell 116:725–736
Woolhead CA, Johnson AE, Bernstein HD (2006) Translation arrest re-
quires two-way communication between a nascent polypeptide and
the ribosome. Mol Cell 22:587–598
Ziv G, Haran G, Thirumalai D (2005) Ribosome exit tunnel can entropi-
cally stabilize α-helices. Proc Natl Acad Sci U S A 102:18956–
18961
150 J Bioenerg Biomembr (2019) 51:137–150
